Juyeon Seo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer.
Journal: International journal of molecular medicine
Published: August 11, 2025
Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.
Journal: Experimental hematology & oncology
Published: April 14, 2025
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 28, 2023
Deep compression network for enhancing numerical reconstruction quality of full-complex holograms.
Journal: Optics express
Published: July 21, 2023
Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase.
Journal: Cellular and molecular life sciences : CMLS
Published: August 19, 2022
β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features.
Journal: Cancer cell international
Published: August 02, 2022
Visualizing Line Defects in non-van der Waals Bi2O2Se Using Raman Spectroscopy.
Journal: ACS nano
Published: February 15, 2022
Gate-controlled gas sensor utilizing 1D-2D hybrid nanowires network.
Journal: iScience
Published: August 24, 2021
Layer-engineered large-area exfoliation of graphene.
Journal: Science advances
Published: May 07, 2020
Last Updated: 09/26/2026